Table 1 Patient characteristics descriptive analysis of demographic characteristics of study patients (N = 85).

From: Combination use of intravenous ketamine-midazolam as a sedative agent in endoscopic retrograde cholangiopancreatography: a randomized control trial

  

Total

Study groups

Ketamine - Midazolam

Midazolam - Pethidine

(N = 85)

(n = 42)

(n = 43)

Age (Years)

Mean (SD)

57.47(16.24)

56.55(17.02)

58.37 (15.59)

Sex

Male, n (%)

39 (45.9)

17 (40.5)

22 (51.2)

Female, n (%)

46 (54.1)

25 (59.5)

21 (48.8)

Ethnicity

Malay, n (%)

60 (70.6)

24 (57.1)

36 (83.7)

Chinese, n (%)

20 (23.5)

13 (31.0)

7 (16.3)

Indian, n (%)

4 (4.7)

4 (9.5)

0 (0.0)

Others, n (%)

1 (1.2)

1 (2.4)

0 (0.0)

ASA

I, n (%)

41 (48.2)

26 (61.9)

15 (34.9)

II, n (%)

33 (38.8)

8 (19.0)

25 (58.1)

III, (%)

11 (12.9)

8 (19.0)

3 (7.0)

Cardiovascular disease

NA

12

7

5

Hypertension

NA

56

27

29

Diabetes

NA

16

7

9

Chronic kidney disease

NA

3

2

1

Carcinoma

NA

6

5

1

Others

NA

18

11

7

Back to article page